Schedule 13D ownership disclosure

Silence Therapeutics plc

Security class unavailable · CUSIP: G8128Y157

Event date: 2022-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
27,373,392
Percent of class
25.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-22-034741
Form type
SC 13D/A
Filer
Griffiths Richard Ian
CIK
CIK 1846370
Filed
Oct 20, 2022
Reporting period
Aug 16, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub